Board
Thomas Warthoe
Born: 1967
Main occupation: CEO Qlife Aps
Shares: 1 521 053
Warrant series TO2: 14 000
Member of the board since 2020
Entrepreneur with over 20 years of experience in the healthcare industry (and specifically diagnostics). Thomas has founded and developed three biotech companies. In two of the companies Thomas founded, Display System Biotech and Ampligon, successful exits were made. He has successfully entered strategic partnerships and licensing agreements with global diagnostic companies such as Backman Coulter, Shionogi Co and Omron Healthcare over the years.
Dependent of the company and its management and major shareholders.
Other assignments: Board member of Petel Holding A/S, PKV Consult IVS and Chip Diagnostics Inc.
Mette Gross
Born: 1972
Main occupation: own
Shares: 140 766
Warrant series TO2: 71 000
Chairman since 2019
Mette has 20 years of experience from small and large companies as CFO. In recent years, Mette has been involved in the development and listing of two medical technology companies and a SaaS company alongside work with own investments and change management assignments. Mette has an educational background as Master of Finance and Mathematics from Odense University. Previous assignments include: CFO Iconovo AB, CFO Vigmed Holding AB, Director Controlling Coloplast Group and CFO MTG A/S.
Independent of the company and its management and major shareholders.
Other assignments: Chairman of the board of Tendo AB and Octaquest AB. Board member of Anatomic Studios AB, Holm Holding AB (and subsidiaries), MLH Management AB (and subsidiaries), Rehaler A/S and Queen Invest AB.
John Moll
Born: 1978
Main occupation: own
Shares: 315 825
Warrant series TO2: 71 001
Member of the board since 2018 (Qlife Aps 2018-2019)
John Moll is a Swedish entrepreneur and experienced business angel with a focus on Life Science. John has an educational background as a pharmaceutical chemist from the Faculty of Engineering at Lund University. John has founded and sold two companies and is a board member of two biotech companies in Sweden and Denmark.
Independent of the company and its management and major shareholders.
Other assignments: Board member of TIRmed Pharma and Torna Kapital AB.
Ulrik Harrysson
Born: 1969
Main occupation: CEO of SyntheticMR
Shares: 2 000
Warrants series 2021/24: 15 000
Board member since 2021
CEO of SyntheticMR since 2019. Previous roles, during a more than 25-year long career, include international management roles in global companies such as Hermes Medical Solution, HemoCue, Danaher and Pfizer. Ulrik has a master’s degree in Business Administration, specialization in Marketing, from the International Business School in Jönköping.
Independent of the company and its management and major shareholders.
Other assignments: None.
Mikael Persson
Born: 1967
Main occupation: Chief Supply Chain Officer at Stokke
Shares:10 000
Warrants series 2021/24: 25 000
Board member since 2021
8 years global experience in the Med Tech industry in senior positions in Supply Chain and Product Development. Participated and ran several major product developments in collaboration with third parties globally. Previous experience of various positions within Alfa Laval, including VP Operations – Operations Development Manager, Supply Chain Director for Cardo Flow Solutions and Flûgger A/S, EVP Supply Chain & Operations and Product Development ArjoHuntleigh AB and COO Manufacturing Capital Equipment Getinge
Independent of the company and its management and major shareholders.
Other assignments: None.
Mette-Marie Harild
Born: 1958
Main occupation: own
Shares: none
Warrants: none
Board member since 2021
Mette-Marie Harild has a long experience of leading international organizations within the pharma/medical industry, most recently from Medtronic as Regional Vice President ABGI & Nordic. Mette-Marie has a strong focus on customers, sales and change management and has vast experiences of public/private cooperation and purchases.
Mette-Marie is originally a trained dentist and has an Executive MBA in Change Management.
Independent of the company and its management and major shareholders.
Other assignments:
Neurescue och Occlutech
Chairman of AmCham Healthcare Committee and the Danish Chamber of Commerce Life Science Board, and member of the Danish Chamber of Commerce and the Danish Business Development Board under the Ministry of Commerce (Danish Erhvervsfremmebestyrelse)